Fiscal Year Ending August 2026 Financial Summary [Japanese GAAP] (Consolidated)

Overview of Results

Mani, Inc. recorded net sales of 33,018 million yen, operating income of 9,943 million yen, ordinary income of 10,554 million yen, and net income of 7,237 million yen for the fiscal year ending August 2026, achieving significant year-over-year increases in both sales and profits. By segment, dental-related products and Ailes needle-related products achieved higher sales and profits, with a weaker yen and recovery in the China market contributing particularly. For the next fiscal year, the company expects steady growth with net sales of 36,500 million yen, operating income of 10,800 million yen, and net income of 7,600 million yen. Dividends are planned at 41 yen.

Outlook and Impact for Investors

For the fiscal year ending August 2027, consolidated guidance anticipates net sales of 36,500 million yen, operating income of 10,800 million yen, and net income of 7,600 million yen, representing increases in sales and profits while factoring in foreign exchange volatility risk. Given the high overseas exposure, yen appreciation risk is a consideration. Also, with full-scale operation of the Hanaoka Plant leading to higher depreciation, strengthening SG&A and cost control will be key to future profitability. Shareholder returns will continue under a policy of stable dividend increases.